IMAGE: Lung squamous cell carcinoma

Breaking News

Public Release: 28-Jul-2014
Journal of the National Cancer Institute
Study helps compare risks of treatments for early esophageal cancer
A new study, published in the July 2014 issue of the Journal of the National Cancer Institute by Northwestern Medicine researchers, sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer.
Northwestern University Robert H. Lurie Comprehensive Cancer Center's Northwestern Institute for Comparative Effectiveness Research in Oncology

Contact: Bret Coons
bcoons@nmh.org
312-926-2955
Northwestern Memorial Hospital

Public Release: 28-Jul-2014
Practical Radiation Oncology
Two-step decision tree analysis helps inform updates of RT best practices, quality standards
A two-step decision tree analysis, incorporating Donabedian's model, is a feasible process to evaluate and distill the many available quality standards, guidelines, recommendations and indicators in order to update national and international quality standards for radiation therapy, according to a study published in the July-August 2014 issue of Practical Radiation Oncology, the official clinical practice journal of the American Society for Radiation Oncology.

Contact: Michelle Kirkwood
press@astro.org
703-286-1600
American Society for Radiation Oncology

Public Release: 28-Jul-2014
Lancet
New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients
Today, July 28, 2014, is World Hepatitis Day. Dr. Eric Lawitz, from the University of Texas Health Science Center at San Antonio and the Texas Liver Institute, led a national study that identified a simple, pill-only treatment for hepatitis C that can cure 93 percent of patients in 12 weeks. This replaces a long and complicated treatment with many serious side effects. The study results are published today in The Lancet.
Janssen

Contact: Rosanne Fohn
fohn@uthscsa.edu
210-567-3026
University of Texas Health Science Center at San Antonio

Latest Multimedia

One Third Of Cancer Patients Are Killed By a 'Fat-Burning' Process Known as Cachexia

One Third Of Cancer Patients Are Killed By a 'Fat-Burning' Process Known as Cachexia
One third of cancer patients are killed by a 'fat-burning' process known as cachexia.

Contact: Nuria Noriega
nnoriega@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)

Activity Level in Mice

Activity Level in Mice
Mice on hormones exercised more than ones on the current treatment, estrogen blockers, leading to better overall health.

Contact: Elaine Lissner
pr@parsemusfoundation.org
415-839-6304
Parsemus Foundation

Lateral Flow Device

Lateral Flow Device
The lateral-flow device (LFD) detects invasive pulmonary aspergillosis, a notoriously difficult to diagnose disease caused by the fungus Aspergillus.

Contact: Eleanor Gaskarth
e.f.gaskarth@exeter.ac.uk
44-782-730-9332
University of Exeter

  Search News Releases

     

 

 

EurekAlert!